Significance of ammonium compounds on nicotine exposure to cigarette smokers.
Level 5 - mechanism / opinion, no new human data
Narrative review evaluating chemical mechanisms and internal industry documents without systematic review methodology
PubMed 16288944 · doi:10.1016/j.fct.2005.09.007
What was done
Narrative review evaluating published scientific literature and internal tobacco company documents to examine whether ammonium compound additives enhance smoker nicotine exposure via smoke alkalization and free-base nicotine formation.
What was found
The abstract reports no numerical values or effect sizes. It reports that ammonia increases smoke alkalinity, shifting nicotine from non-volatile salts to volatile free base. The observed pharmacokinetic shifts following ammoniation (shorter half-life [t_1/2] and higher maximum concentration [c_max]) are identified as being predominantly driven by higher total nicotine concentrations in smoke rather than an increased absorption rate of free-base nicotine across the respiratory tract.
Why it matters
Explains the pharmacological and chemical mechanisms behind tobacco ammoniation, providing mechanistic evidence relevant to tobacco product regulation and additive restrictions.
Limits
As a narrative review, it lacks systematic search parameters, formal study quality grading, and quantitative meta-analysis. The abstract does not specify the number of analyzed documents or human trials, and notes that further independent empirical studies are necessary to firmly establish bioavailability effects.
Cited by
- partial Adding ammonia compounds like diammonium phosphate converts nicotine to freebase form, allowing it to cross the blood-brain barrier faster than natural nicotine salts.